A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia
Status:
Terminated
Trial end date:
2020-08-25
Target enrollment:
Participant gender:
Summary
This study evaluates the use of tranexamic acid (TXA) in addition to standard therapy in
children receiving chemotherapy or blood and/or marrow transplantation to decrease the risk
of bleeding. Half of participants will receive tranexamic acid and half of participants will
receive placebo.